Author: Joe Carlson

Filter by Popularity: - - - -
Thumbnail
No correlation found in its data between paclitaxel exposure with patient deaths through 5 years, Medtronic says. [Read More]
Thumbnail
Providers are rethinking using paclitaxel-coated devices in the legs after publication of research detecting higher death rates. [Read More]
A flash of sparkles appears as an industrial-grade laser unleashes a blast of energy, precisely manufacturing channels in laminated tape for a medical device component.Someday,... [Read More]
A flash of sparkles appears as an industrial-grade laser unleashes a blast of energy, precisely manufacturing channels in laminated tape for a medical device component.Someday,... [Read More]
Thumbnail
Company said some devices temporarily lose ability to pace the heart. [Read More]
Researchers in December flagged higher patient death rates, but device companies have questioned the findings. [Read More]
Results were rolled out at an industry conference. [Read More]
Using robotic-assisted equipment can improve precision, lessen complications... [Read More]
Tags: Medtronic - bets - big
Medtronic had taken a growing stake in the Israeli firm and started distributing its products last year. [Read More]
A label change could expand the market for the device maker's CoreValve Evolut system. [Read More]
Recalled ICD devices made at Puerto Rico facility had potential electrical flaws. [Read More]
As a lover of history, Jules Smith also was fascinated with the new, playing a key role in the founding of a first-of-its-kind community in... [Read More]
Summary Whitman Large goes in here at 18 pts over 20 pts leading more words go here to fill this space more words xxgx... [Read More]
After a series of computer security problems in medical devices, the Food and Drug Administration is taking steps to make sure companies do as much... [Read More]
Industry, officials work to boost security of medical devices. [Read More]
Industry, officials work to boost security of medical devices. [Read More]
The St. Paul firm is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke. [Read More]
Sales of Augmenix's SpaceOAR hydrogel are projected to nearly double in the next year. [Read More]
Sales of Augmenix's SpaceOAR hydrogel are projected to nearly double in the next year. [Read More]
The nonprofit will focus on older drugs that have become scarce and pricey. [Read More]
Jump To: